Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Situated in the core of the NC Research Triangle, the site at Camp Helix Innovation Park is a substantial regional investment ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Sotorasib was approved in the US as Lumakras in May, becoming the first KRAS drug to reach the market after decades of R&D effort to find a compound that could hit the elusive target, long ...

after one prior systemic therapy – the same indication given to Amgen's Lumakras (sotorasib) when it became the first KRAS inhibitor to be approved in the US in May 2021. While the wording on ...

The combination of sotorasib (Lumakras) and panitumumab (Vectibix) has received FDA approval for the treatment of previously treated KRAS G12C-mutated metastatic colorectal cancer. In the CodeBreaK ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them as new standard treatments for certain colorectal cancer patients.

After hours: 7:50:10 p.m. EST ...

The phase 3 LEAP-015 trial evaluated the efficacy and safety of pembrolizumab with lenvatinib in patients with advanced/metastatic gastroesophageal cancer.